Authors: RUSTHOVEN JJ QUIRT IC ISCOE NA MCCULLOCH PB JAMES KW LOHMANN RC JENSEN J BURDETTERADOUX S BODURTHA AJ SILVER HKB VERMA S ARMITAGE GR ZEE B BENNETT K HEDLEY D FINE S MYERS R KING M MERTENS W TAYLOR M CANO P MALIK S VERGIDIS D SHORE S DUDGEON D SMYLIE M WILSON K KNOWLING M SAMOSH M GIESBRECHT J HUAN S SKILLINGS J GREGG R BELANGER K POLLAK M LATREILLE J BATIST G BOOS G GRUNER P HINGS I LOUTFI A THIRLWELL M TRUDEAU M JOLIVIT J AYOUB J CHARPENTIER D CLEMENT S YELLE L BELANGER D SHIBATA H

Citation: Jj. Rusthoven et al., RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL COMPARING THE RESPONSE RATES OF CARMUSTINE, DACARBAZINE, AND CISPLATIN WITH AND WITHOUT TAMOXIFEN IN PATIENTS WITH METASTATIC MELANOMA, Journal of clinical oncology, 14(7), 1996, pp. 2083-2090

Authors: WALKER I BENGER A BROWMAN G MEYER R NICHOLSON W SAMOSH M

Citation: I. Walker et al., CRITICAL-APPRAISAL OF INTERFERON THERAPY FOR CHRONIC MYELOID-LEUKEMIA, Blood, 86(10), 1995, pp. 3201-3201

Authors: LEVINE M HIRSH J GENT M ARNOLD A WARR D FALANGA A SAMOSH M BRAMWELL V PRITCHARD KI STEWART D GOODWIN P

Citation: M. Levine et al., DOUBLE-BLIND RANDOMIZED TRIAL OF VERY-LOW-DOSE WARFARIN FOR PREVENTION OF THROMBOEMBOLISM IN STAGE-IV BREAST-CANCER, Lancet, 343(8902), 1994, pp. 886-889

Authors: LEVINE MN HIRSH J GENT M ARNOLD A WARR D FALANGA A SAMOSH M BRAMWELL V PRITCHARD K STEWART D GOODWIN P DICKSON L

Citation: Mn. Levine et al., A DOUBLE-BLIND RANDOMIZED TRIAL OF MINI-DOSE WARFARIN FOR THE PREVENTION OF THROMBOEMBOLISM (TE) IN PATIENTS WITH STAGE-IV BREAST-CANCER, Thrombosis and haemostasis, 69(6), 1993, pp. 981-981